Selumetinib: a selective MEK1 inhibitor for solid tumor treatment
Mohaddeseh Hedayat, Reza Jafari, Naime Majidi Zolbanin
Topics & Concepts
SelumetinibMelanomaCancer researchMAPK/ERK pathwayCancerMEK inhibitorMedicineColorectal cancerInternal medicineKRASOncologyKinaseBiologyGeneticsMelanoma and MAPK PathwaysPI3K/AKT/mTOR signaling in cancerCancer Mechanisms and Therapy